In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Series B brings in $12.6mm so far for 23andMe

Executive Summary

23andMe (genetic testing) has raised $12.6mm of a proposed $24.3mm Series B venture round. There were two investors--Google invested $2.6mm and Sergey Brin, one of the Internet company's founders and husband of 23andMe co-founder Anne Wojcicki, provided the rest.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Services
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register